THYROID EYE DISEASE · TREATMENT INFORMATION
TEPEZZA® treatment information for thyroid eye disease.
Neutral, educational information about TEPEZZA (teprotumumab) for selected thyroid eye disease patients.
WHAT IT IS
About TEPEZZA
TEPEZZA (teprotumumab) is an FDA-approved infusion medication for thyroid eye disease. It works by blocking a receptor called IGF-1R, which contributes to the inflammation and tissue expansion behind the eyes in TED. In clinical studies it reduced eye bulging (proptosis), double vision, and inflammation in appropriately selected patients.
PATIENT SELECTION
Who may be a candidate
Medication may be appropriate for selected patients depending on disease activity, severity, medical history, and risk profile. Not every patient with thyroid eye disease is a candidate, and for some patients observation, other medical treatment, or surgery is the more appropriate path.
WHAT TREATMENT INVOLVES
The course of therapy
TEPEZZA is given as an intravenous infusion once every 3 weeks, for a total of 8 infusions over approximately 5 months. Dosing is based on body weight. Response is monitored throughout the course.
Safety
An honest conversation about risk
Reported side effects include muscle cramps, nausea, hair loss, fatigue, elevated blood sugar, hearing changes, and infusion reactions, among others. It can cause harm in pregnancy. A full review of history — including hearing and blood sugar — precedes any recommendation, with monitoring during treatment.
Potential benefits, risks, alternatives, contraindications, and monitoring requirements should be reviewed with a qualified physician before treatment.
PHYSICIAN BACKGROUND
Experience with this class of therapy
Dr. Ugradar has published peer-reviewed research on IGF-1R–targeted therapy for thyroid eye disease and has served as a clinical-trial investigator and advisor in the development of treatments in this class. Advisory relationships are disclosed for transparency and do not influence individual recommendations.
COVERAGE & ACCESS
Insurance and authorization
TEPEZZA is frequently covered by insurance for appropriate patients; coverage depends on the plan and documentation. The office team handles benefits verification and prior authorization for patients and referring physicians.
Treatment details on this page are verified against current prescribing information before publication.